Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 189616435 | intergenic variant | A/G;T | snv | 0.39 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 0.080 | 3 | 189625454 | intergenic variant | A/-;AA;AAA;AAAA | delins |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.080 | 3 | 189625454 | intergenic variant | A/-;AA;AAA;AAAA | delins |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.080 | 3 | 189625454 | intergenic variant | A/-;AA;AAA;AAAA | delins |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 3 | 189630622 | upstream gene variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.851 | 0.080 | 3 | 189630622 | upstream gene variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.851 | 0.080 | 3 | 189630622 | upstream gene variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.851 | 0.080 | 3 | 189630622 | upstream gene variant | G/A | snv | 0.13 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 189638432 | intron variant | G/A | snv | 0.34 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
0.827 | 0.080 | 3 | 189638472 | intron variant | T/C | snv | 0.45 |
|
Neoplasms; Respiratory Tract Diseases | 0.750 | 1.000 | 7 | 2011 | 2019 | |||||||
|
0.827 | 0.080 | 3 | 189638472 | intron variant | T/C | snv | 0.45 |
|
Neoplasms; Respiratory Tract Diseases | 0.750 | 1.000 | 6 | 2011 | 2015 | |||||||
|
0.827 | 0.080 | 3 | 189638472 | intron variant | T/C | snv | 0.45 |
|
Neoplasms; Respiratory Tract Diseases | 0.050 | 1.000 | 5 | 2011 | 2015 | |||||||
|
0.827 | 0.080 | 3 | 189638472 | intron variant | T/C | snv | 0.45 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.080 | 3 | 189638472 | intron variant | T/C | snv | 0.45 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 3 | 189639152 | intron variant | A/G | snv | 0.45 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 3 | 189639410 | intron variant | G/T | snv | 0.45 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 3 | 189639410 | intron variant | G/T | snv | 0.45 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 3 | 189639813 | intron variant | T/C | snv | 0.45 |
|
Neoplasms | 0.710 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 3 | 189639813 | intron variant | T/C | snv | 0.45 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.080 | 3 | 189665394 | intron variant | C/T | snv | 0.38 |
|
Neoplasms | 0.840 | 1.000 | 5 | 2010 | 2014 | |||||||
|
0.807 | 0.080 | 3 | 189665394 | intron variant | C/T | snv | 0.38 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 1.000 | 4 | 2012 | 2015 | |||||||
|
0.807 | 0.080 | 3 | 189665394 | intron variant | C/T | snv | 0.38 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 1.000 | 4 | 2012 | 2015 | |||||||
|
0.807 | 0.080 | 3 | 189665394 | intron variant | C/T | snv | 0.38 |
|
Neoplasms; Respiratory Tract Diseases | 0.040 | 1.000 | 4 | 2012 | 2015 | |||||||
|
0.807 | 0.080 | 3 | 189665394 | intron variant | C/T | snv | 0.38 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2011 | 2011 | |||||||
|
0.807 | 0.080 | 3 | 189665394 | intron variant | C/T | snv | 0.38 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 |